Compare AVTR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTR | EXAS |
|---|---|---|
| Founded | 1904 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 11.0B |
| IPO Year | 2019 | N/A |
| Metric | AVTR | EXAS |
|---|---|---|
| Price | $11.19 | $101.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 20 |
| Target Price | $15.31 | ★ $77.94 |
| AVG Volume (30 Days) | 8.4M | ★ 10.8M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,575,200,000.00 | $3,082,033,000.00 |
| Revenue This Year | N/A | $19.40 |
| Revenue Next Year | $0.17 | $13.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.47 |
| 52 Week Low | $10.62 | $38.81 |
| 52 Week High | $23.32 | $101.95 |
| Indicator | AVTR | EXAS |
|---|---|---|
| Relative Strength Index (RSI) | 43.45 | 89.65 |
| Support Level | $10.86 | $100.95 |
| Resistance Level | $11.57 | $101.95 |
| Average True Range (ATR) | 0.35 | 0.35 |
| MACD | 0.06 | -0.87 |
| Stochastic Oscillator | 40.94 | 61.17 |
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.